Agenus Inc.
General ticker "AGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $93.5M (TTM average)
Agenus Inc. follows the US Stock Market performance with the rate: 11.1%.
Estimated limits based on current volatility of 4.6%: low 4.53$, high 4.97$
Factors to consider:
- Total employees count: 162 as of 2000
- US accounted for 0.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Inability to obtain additional financing, High development costs, Labor/talent shortage/retention, Regulatory and compliance, Market competition
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.44$, 7.21$]
- 2026-12-31 to 2027-12-31 estimated range: [2.40$, 6.96$]
Financial Metrics affecting the AGEN estimates:
- Positive: with PPE of 7.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -159.08 <= 0.07
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0.03 > -0.65
- Positive: -3.36 < Return on assets ratio (scaled to [-100,100]) of 0.05
- Negative: negative Industry operating income (median)
Short-term AGEN quotes
Long-term AGEN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $156.87MM | $107.42MM | $114.20MM |
| Operating Expenses | $316.42MM | $227.89MM | $134.75MM |
| Operating Income | $-159.55MM | $-120.47MM | $-20.56MM |
| Non-Operating Income | $-97.89MM | $-111.80MM | $17.47MM |
| Interest Expense | $97.92MM | $117.63MM | $55.62MM |
| R&D Expense | $234.57MM | $155.53MM | $79.34MM |
| Income(Loss) | $-257.44MM | $-232.27MM | $-3.08MM |
| Profit(Loss)* | $-245.76MM | $-227.21MM | $0.12MM |
| Stockholders Equity | $-160.33MM | $-326.38MM | $-271.11MM |
| Assets | $313.91MM | $226.27MM | $226.80MM |
| Operating Cash Flow | $-224.20MM | $-158.31MM | $-158.31MM |
| Capital expenditure | $9.95MM | $0.58MM | $0.58MM |
| Investing Cash Flow | $3.40MM | $0.03MM | $0.03MM |
| Financing Cash Flow | $119.87MM | $122.84MM | $122.84MM |
| Earnings Per Share** | $-13.73 | $-10.58 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.